AVANIR Pharmaceuticals (NASDAQ:AVNR)
CAPS Rating:
A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.
A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.
Recs
I FOOLISHLY choose this stock and based on a crazy madman and have watched it plummet ever since.